期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性心肌梗死患者肌钙蛋白I检测的价值分析 被引量：3

下载PDF
导出
摘要 目的:分析肌钙蛋白(ICTnI)检测对急性心肌梗死的应用价值。方法:采用化学发光免疫系统access2检测肌钙蛋白Ⅰ。结果:肌钙蛋白I检测阳性率高于心肌酶(CK-MB、CK、LDH、GOT)。结论:肌钙蛋白Ⅰ具有高度的特异性和血清肌钙蛋白Ⅰ量与心肌梗死面积呈线性关系(r=0.95)。其高度的敏感性和较长的诊断窗口成为指导心肌梗死诊疗的较好检查。
作者 王爱斌 胡雅琴
机构地区 清水县人民医院检验科
出处 《甘肃医药》 2013年第1期62-63,共2页 Gansu Medical Journal
关键词 急性心肌梗死 肌钙蛋白I 心肌酶(CK CK—MB LDH GOT)检测
分类号 R542.22 [医药卫生—心血管疾病]
  • 相关文献

参考文献3

二级参考文献8

  • 1Apple FS,Smith SW,Pearce LA. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presention with symptoms suggestive of acute coronary syndrome[J].Clinical Chemistry,2008,(04):723-728.doi:10.1373/clinchem.2007.097162.
  • 2James S,Armstrong P,Califf R. Troponin T levels and risks of 30-day outcomes in patients with the acute coronary syndrome:prospective verification in the GUSTO-Ⅳ trial[J].American Journal of Medicine,2003,(03):178-184.doi:10.1016/S0002-9343(03)00348-6.
  • 3Apple FS. A new season for cardiac troponin assays:it′s time to keep a scorecard[J].Clinical Chemistry,2009,(07):1303-1307.doi:10.1373/clinchem.2009.128363.
  • 4James S,Flodin M,Johnston N. The antibody configurations of cardiac troponin I assays may determine their clinical performance[J].Clinical Chemistry,2006,(05):832-837.doi:10.1373/clinchem.2005.064857.
  • 5Apple FS,Pearce LA,Smith SW. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events[J].Clinica Chimica Acta,2009,(05):930-937.
  • 6Hjortsh(o)j S,Dethlefsen C,Kristensen SR. Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers[J].Scandinavian Journal of Clinical and Laboratory Investigation,2008,(03):130-133.
  • 7Wilson SR,Sabatine MS,Braunwald E. Dectection of myocardial injury in patients with unstable angiana using a novel nanoparticle cardiac troponin I assays:observations from the PROTECT-TIMI 30 Trial[J].American Heart Journal,2009,(03):386-391.doi:10.1016/j.ahj.2009.06.011.
  • 8Morrow DA,Cannon CP,Rifai N. Ability of minor elevations of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction:results from a randomized trial[J].Journal of the American Medical Association,2001,(19):2405-2412.doi:10.1001/jama.286.19.2405.

共引文献623

同被引文献40

  • 1ROGER V L, GO A S, LLOYD-JONES D M, et al. Execu- tive summary: heart disease and stroke statistics-2012 up- date: a report from the American Heart Association[J]. Circu- lation, 2012,125(1) :188-197.
  • 2TERKELSEN C J, LASSEN J F, NORGAARD B L, et al Mortality rates in patients with ST-elevation vs. non-ST-eleva tion acute myocardial infarction: observations from an unse lected cohort[J]. European Heart Journal, 2005,26(1): 18-26.
  • 32012 Writing Committee Members, JNEID H, ANDERSON J L, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstalale angina/non-ST-ele- vation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update) : a report of the American College of Cardiology Foundatlon/American Heart Association Task Force on practice guidelines[J]. Circulation, 2012,126 (7):875-910.
  • 4DEWOOD M A, STIFTER W F, SIMPSON C S, et al. Coronary arteriographic findings soon after non Q-wave myocardial infarction[J]. New England Journal of Medicine, 1986,315 (7):417-423.
  • 5BEN GAL Y, MOSES J W, MEHRAN R, et al. Surgical ver sus pereutaneous revascularization for multivessel disease in patients with acute coronary syndromes ana!.ysis from the ACUITY (acute catheterization and urgent intervention triage strategy) trial[J]. JACC-Cardiovascular Interventions, 2010,3 (10) : 1059-1067.
  • 6GREENBERG D, BAKHAI A, NEIL N, et al. Modeling the impact of patient and Iesion characteristics on the cost-effec- tiveness of drug-Eluting stents (abstr)[J]. J Am Coll Cardiol, 2003,41 (SupplA) :538A.
  • 7GLASER R, SELZER F, FAXON D P, et al. Clinical pro- gression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention[J]. Circulation, 2005,111(2): 143-149.
  • 8EGGERS K M, JAMES S, VENGE P, et al. Prognostic impli- cations of changes in cardiac troponin I levels in patients with non-ST elevation acute coronary syndrome[J]. Biomarkers, 2013,18(8):668-672.
  • 9APPLE F S, PEARCE L A, SMITH S W, et al. Role of mo- nitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events[J]. Clinical Chemistry, 2009,55 (5) : 930-937.
  • 10MARTENSSON S, GYRD-HANSEN D, PRESCOTT E A, et al. Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark [J]. BMJ Open, 2014,4(1): e004052.

引证文献3

二级引证文献7

甘肃医药
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部